Oct 28, 2005 by Stephen D. SimpsonSlower Growth at Yellow RoadwayResults from this large less-than-truckload player suggest the market has gotten tougher.
Oct 28, 2005 by Stephen D. SimpsonIs Curtiss-Wright for You?Strong cyclical markets are boosting results, but the stock already reflects that.
Oct 28, 2005 by Stephen D. SimpsonBristol-Myers' Bad MojoThe possible loss of Pargluva is a blow to a pharmaceutical company already hurting for growth.
Oct 28, 2005 by Stephen D. SimpsonWill ABB Put It Together?This company has screwed up royally in the past, but new management might be the key to better long-term results.
Oct 27, 2005 by Stephen D. SimpsonAstraZeneca Prepares for a Dry SpellA weak late-stage pipeline will make for challenging earnings growth in the coming years.
Oct 27, 2005 by Stephen D. SimpsonA Balanced Attack for GlaxoA broad suite of drugs, a huge sales force, and a solid pipeline make GlaxoSmithKline an appealing pharmaceutical company.
Oct 27, 2005 by Stephen D. SimpsonWill Smith & Nephew Keep Flexing?This smaller orthopedic company has competitive products, but industry trends could hurt it.
Oct 27, 2005 by Stephen D. SimpsonExxonMobil Floats OnThe oil giant needs to work on production, but it's a cash flow giant nonetheless.
Oct 27, 2005 by Stephen D. SimpsonBlack & Decker Nails ItThis leading toolmaker crafts strong results yet again.
Oct 27, 2005 by Stephen D. SimpsonCan ESRX Spell P-r-o-f-i-t-s?A company focused on lowering medical costs sounds like a good idea, but Fools should dig deeper.
Oct 27, 2005 by Stephen D. SimpsonWhat's New With Novo?Novo Nordisk is a good play on diabetes, but will new drugs reduce the need for insulin?
Oct 26, 2005 by Stephen D. SimpsonCardinal's Tweet More SweetChanges to the business are working out well, but the stock price already reflects it.
Oct 26, 2005 by Stephen D. SimpsonWay to Operate, Intuitive SurgicalGrowth has been red-hot even though most systems aren't used to their full capabilities.
Oct 26, 2005 by Stephen D. SimpsonVCA Antech Still BarkingThe business model has some risk, but it has already delivered rewards.
Oct 26, 2005 by Stephen D. SimpsonFinancing Ballard's DreamsBallard Power has the chance to reposition itself; will it blow it?
Oct 26, 2005 by Stephen D. SimpsonUMC for You and Me?A market glut walloped earnings this year. Will a recovery make these shares a good buy?
Oct 26, 2005 by Stephen D. SimpsonBoard With ExcellenceIf you can look past the valuation, a great company lies beneath.
Oct 26, 2005 by Stephen D. SimpsonW.R. Berkley: Bold Yet Beautiful?Berkley could benefit from the recent hurricanes if insurers turn to focusing on profitability.
Oct 26, 2005 by Stephen D. SimpsonA Whiff of Value From IFF?Can underfollowed mean undervalued? Maybe so, in the case of International Flavors and Fragrances.
Oct 25, 2005 by Stephen D. SimpsonIs Rent-A-Center Finally a Value?One Fool is still extremely suspicious of management, but it's possible that potential value is beginning to show itself.
